Oncogene activation of human keratin 18 transcription via the Ras signal transduction pathway.
Author(s) -
Roumen Pankov,
Akihiro Umezawa,
Richard A. Maki,
Channing J. Der,
Charlotte A. E. Hauser,
Robert G. Oshima
Publication year - 1994
Publication title -
proceedings of the national academy of sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.011
H-Index - 771
eISSN - 1091-6490
pISSN - 0027-8424
DOI - 10.1073/pnas.91.3.873
Subject(s) - enhancer , transcription factor , signal transduction , biology , carcinogenesis , keratin , oncogene , ectopic expression , microbiology and biotechnology , transcription (linguistics) , proto oncogene proteins c myc , transduction (biophysics) , cancer research , genetics , gene , biochemistry , cell cycle , linguistics , philosophy
Keratin 8 (K8) and keratin 18 (K18) are intermediate filament proteins normally expressed in simple epithelial tissues and persistently expressed in a wide variety of carcinomas. Ectopic expression of K8 and K18 occurs in some epidermal and murine skin carcinomas induced by chemical carcinogenesis or oncogenic ras expression. We show here that K18 is a direct target of the Ras signal transduction pathway, by demonstrating that activated Ha-Ras, as well as activated Src, Lck, or Raf, stimulates the transcription of K18. This activation is mediated by an enhancer element containing essential and closely spaced Ets and AP-1 transcription factor binding sites. Oncogene activation of K18 transcription provides a molecular explanation for the persistent and sometimes unexpected expression of K18 in such a wide variety of tumors.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom